Open and experimentally grounded benchmarks reshape protein AI

OpenBind and related efforts including O3DC, RushData, on-premises synthesis, AWS's challenge, and BioNeMo-based workflows address reproducibility and the computational-to-wet-lab handoff. Reported computational gains and commercial partnerships remain preclinical signals rather than evidence of translational validity.